John Neis sold $732 of CLRB
director at Cellectar Biosciences, Inc.. 198 shares at an average of $3.70, traded Dec 12, 2025, filed Dec 16, 2025.
Score components
- +15RoleDirector
- 0Trade size$732 at market
- +20Share of holdings soldSold 95% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +14.8%, 3m +3.8%, 6m -23.0%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-25-121691, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 12, 2025 | SOpen-market sale Common Stockindirect: See Footnote | -198 | $3.70 | $732 | 10 | Dec 16, 2025 |
Related signals
Other insiders at Cellectar Biosciences, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 51Moderate | Cellectar Biosciences, Inc. | James Caruso V Chief Executive Officer | $25k 8,680 shares | +75% | |
| 46Moderate | Cellectar Biosciences, Inc. | Jarrod Longcor Chief Operating Officer | $25k 8,680 shares | +74% | |
| 75Notable | Cellectar Biosciences, Inc. | James Caruso V Chief Executive Officer | $50k 10,000 shares | +611% | |
| 65Notable | Cellectar Biosciences, Inc. | Chad J Kolean Chief Financial Officer | $25k 5,000 shares | +353% | |
| 70Notable | Cellectar Biosciences, Inc. | Jarrod Longcor Chief Operating Officer | $50k 10,000 shares | +361% | |
| 30Weak | CLRBbuy Cellectar Biosciences, Inc. | Jarrod Longcor Chief Operating Officer | $8,400 30,000 shares | +56% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.